Portal de Periódicos da CAPES

Regulation of Amyloid Precursor Protein Cleavage

1999; Wiley; Volume: 72; Issue: 2 Linguagem: Inglês

10.1046/j.1471-4159.1999.0720443.x

1471-4159

Julia Mills, Peter B. Reiner,

Cholinesterase and Neurodegenerative Diseases

Abstract : Multiple lines of evidence suggest that increased production and/or deposition of the β‐amyloid peptide, derived from the amyloid precursor protein, contributes to Alzheimer's disease. A growing list of neuro‐transmitters, growth factors, cytokines, and hormones have been shown to regulate amyloid precursor protein processing. Although traditionally thought to be mediated by activation of protein kinase C, recent data have implicated other signaling mechanisms in the regulation of this process. Moreover, novel mechanisms of regulation involving cholesterol‐, apolipoprotein E‐, and stress‐activated pathways have been identified. As the phenotypic changes associated with Alzheimer's disease encompass many of these signaling systems, it is relevant to determine how altered cell signaling may be contributing to increasing brain amyloid burden. We review the myriad ways in which first messengers regulate amyloid precursor protein catabolism as well as the signal transduction cascades that give rise to these effects.